Merck & Co., Inc. (MRK) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Drug Manufacturers - General Branche. Der Hauptsitz des Unternehmens ist in Rahway, NJ, United States. Der aktuelle CEO ist Robert Davis.
MRK hat IPO-Datum 1978-01-13, 73,000 Vollzeitbeschäftigte, gelistet an der NYSE, eine Marktkapitalisierung von $296.59B.
Merck & Co., Inc. is a global healthcare company founded in 1891 and headquartered in Kenilworth, New Jersey. Operating through two primary segments—Pharmaceutical and Animal Health—the company develops and markets a diverse portfolio of human health pharmaceuticals spanning oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular disease, and diabetes treatment, along with preventive vaccines for pediatric, adolescent, and adult populations. The Animal Health segment manufactures veterinary pharmaceuticals, vaccines, and health management solutions, complemented by digital products for animal identification and monitoring. Merck distributes its products to drug wholesalers, retailers, hospitals, government agencies, managed care providers, and healthcare professionals worldwide, while maintaining strategic collaborations with leading pharmaceutical companies including AstraZeneca, Bayer, Eisai, Ridgeback Biotherapeutics, and Gilead Sciences to advance long-acting HIV treatments.
